Elevation Oncology reports Q2 EPS (18c), consensus (22c)
PremiumThe FlyElevation Oncology reports Q2 EPS (18c), consensus (22c)
4M ago
Elevation Oncology to evaluate combination in gastroesophageal junction cancer
Premium
The Fly
Elevation Oncology to evaluate combination in gastroesophageal junction cancer
5M ago
Elevation Oncology initiated with an Overweight at Piper Sandler
Premium
The Fly
Elevation Oncology initiated with an Overweight at Piper Sandler
6M ago
Elevation Oncology reports Q1 EPS (23c), consensus (20c)
PremiumThe FlyElevation Oncology reports Q1 EPS (23c), consensus (20c)
7M ago
Elevation Oncology presents preclinical proof-of concept data for HER3-ADC
Premium
The Fly
Elevation Oncology presents preclinical proof-of concept data for HER3-ADC
8M ago
Lori Hu Resigns, Darcy Mootz Joins Elevation Oncology Board
Premium
Company Announcements
Lori Hu Resigns, Darcy Mootz Joins Elevation Oncology Board
8M ago
GoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls
PremiumThe FlyGoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls
9M ago
Elevation Oncology initiated with an Outperform at JMP Securities
Premium
The Fly
Elevation Oncology initiated with an Outperform at JMP Securities
9M ago
Elevation Oncology doses first patient in Japan in Phase 1 trial of EO-3021
Premium
The Fly
Elevation Oncology doses first patient in Japan in Phase 1 trial of EO-3021
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100